GSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNUXlQTnc4VFk4Uk1DZ194V2xNcEhDVkF4aDNmRXhtbnBaZVJ2TFpjSFRSUmF2Skh6R3FVZGNpWUVUckQxdDB3a1lOdVlPNk45REYzRzBLdk5sSnM3X3owa0EtN0k3VWVTODRkQ3JfVzFDOHNhNm5DWXF3Vm5rX0lJNVN5YVV6a1dLX3JNVFprZnZTMDJIOGlJV0hab21VLWxycDR6ZFNFV1E2cHR1REtkckVVd0szMFNMY25fN0w0YnpiV0NpdGdBbW1TSE90V0xxYko1eTZ4TQ?oc=5" target="_blank">GSK, Hansoh's targeted cancer drug hits main survival goal in China trial</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMChina approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
August 27, 2026 at 05:02 PMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AM